Bundy Group, a 32-year-old, industry-focused investment bank, announces that it has advised Bio-Cide International (Bio-Cide), a leading specialty chemicals and disinfectants manufacturing organization, in a sale to Kemin Industries, a global ingredient manufacturer that serves such markets as food safety and animal health. The transaction was led by Clint Bundy, Stewart Carlin, and Jim Mullens, Managing Directors with Bundy Group.
Within the chemicals market, providers of antimicrobial and antiviral specialty chemicals have seen their market potential and value increase substantially since the outbreak of COVID-19. With the global economy’s heightened focus on disinfectants and hygiene solutions, those producers retain an outsized attractiveness in a volatile market.
“We enjoyed working with the Danner Family, majority owners of Bio-Cide, and managing the sale process, which resulted in strong domestic and international buyer interest,” stated Stewart Carlin from the Bundy Group team. “We were excited to see such a quality strategic buyer recognize the strong value that Bio-Cide offers to a new owner and to be the selected party.”
Clint Bundy stated, “Over its nearly 50-year history, Bio-Cide has become a leader in the fields of disinfectants and chemicals, as the company’s products are critical for the food safety and animal health markets. Kemin Industries offers Bio-Cide an expanded platform for growth, and we are excited to see what the future holds for our client within the Kemin organization.”
Jeff Danner, Chief Executive Officer and Chairman of the Board of Directors for Bio-Cide, indicated that the company hired Bundy Group “based on the team’s experience in the chemical industry, ability to understand and best position clients, and strong reputation.” Mr. Danner further added, “We were nothing but impressed with Bundy Group’s thorough and competitive-driven process, as well as its management of complex matters, all of which resulted in a premium valuation for the shareholders and a great new home for the company and employees. We were more than pleased with your team’s work and the exceptional outcome that you delivered.”
Bio-Cide International, headquartered in Norman, Oklahoma, has been a leading, multi-specialty source of chlorine dioxide based antimicrobial technology for over 49 years. The company has pioneered processes that have revolutionized disinfection and sanitation practices around the globe and manufactures a versatile line of chemical disinfectants, sanitizers, deodorizers, and preservatives.
Bio-Cide International has been the leader in stabilized chlorine dioxide and acidified sodium chlorite applications instrumental in the elimination of microorganisms found in the medical professions, water treatment, food processing plants, dairy and bottling plants, the seafood industry, air duct ventilation systems, the oil field industry, and the animal health industry.
Kemin Industries is a global ingredient manufacturer that strives to sustainably transform the quality of life every day for 80 percent of the world with its products and services. The company supplies over 500 specialty ingredients for human and animal health and nutrition, pet food, aquaculture, nutraceutical, food technologies, crop technologies, textile, biofuels, and animal vaccine industries.
For over half a century, Kemin has been dedicated to using applied science to address industry challenges and offer product solutions to customers in more than 120 countries. Kemin provides ingredients to feed a growing population with its commitment to the quality, safety, and efficacy of food, feed, and health-related products.
Established in 1961, Kemin is a privately held, family-owned-and-operated company with more than 2,800 global employees and operations in 90 countries, including manufacturing facilities in Belgium, Brazil, China, India, Italy, Russia, San Marino, Singapore, South Africa, and the United States.
Bundy Group is an industry-focused investment bank that specializes in representing business owners and management teams in business sales, acquisitions, and capital raises. The 32-year-old firm has closed more than 250 transactions, specializing in several industries, including chemicals, healthcare and life sciences, technology, energy and power, and infrastructure. For more information about our industry expertise and other recent transactions, visit https://bundygroup.com/industry-expertise/.
Securities offered through Bundy Group Securities, LLC, a registered broker-dealer and member of FINRA. Check the background of Bundy Group Securities, LLC at FINRA's BrokerCheck. Testimonials may not be representative of the experience of other customers and are no guarantee of future performance or success.
